Abstract
We report on a female case of rheumatoid arthritis (RA) with hepatitis C virus comorbidity. The patient was treated once weekly over ten consecutive weeks with Adacolumn® device. Clinical assessment and HCV-RNA concentration were monitored at weeks—1, 4, 9, 14 and during follow-up over 6 months. At the end of the treatment: the number of tender and swollen joints, patient’s global assessment of disease activity (VAS), physician’s VAS, C-reactive protein (CRP) decreased, respectively; ACR response was >20. This improvement was maintained for over 2 months. At week 38, the patient was re-treated achieving again an ACR response >20.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Matsubara T, Ziff M (1987) Basement membrane thickening of postcapillary venules and capillaries in rheumatoid synovium Immunoelectron microscopic and electron microscopic morphometric analysis. Arthritis Rheum 30(1):18–30
Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF (1986) The development of disability in rheumatoid arthritis. Arthritis Rheum 29(4):494–500
Skretkowicz J, Skretkowicz-Szarmach K (2006) Genetics in rheumatoid arthritis (RA). Pol Merkur Lekarski 20(118):468–70
Baldini C, Delle Sedie A, Bombardieri S (2005) From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clin Exp Rheumatol 23(6):893–904
Wallace DJ, Goldfinger D, Gatti R, Lowe C, Fan P, Bluestone R, Klinenberg JR (1979) Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis. Arthritis Rheum 22(7):703–710
Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Kataharada K, Ishizuka T, Kawakami M, Nakamura H (1999) Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 42(3):431–437
Nagashima M, Yoshino S, Tanaka H, Yoshida N, Kashiwagi N, Saniabadi A R (1998) Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study. Rheumatol Int 18:113–118
Ohara M, Saniabadi AR, Kokuma S, Hirata I, Adachi M, Agishi T, Kasukawa R (1997) Granulocytapheresis in the treatment of patients with rheumatoid arthritis. Artif Organs 21(9):989–994
Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, Asakura H, Tanaka T, Kasukawa R, Kimura K, Suzuki Y, Nagamachi Y, Muto T, Nagawa H, Iizuka B, Baba S, Nasu M, Kataoka T, Kashiwagi N, Saniabadi ARJ (2001) Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. Clin Apher 16(1):1–9
Sanmarti R, Marsal S, Valverde J, Casado E, Lafuente R, Kashiwagi N, Rodriguez-Cros JR, Erra A, Reina D, Gratacos J (2005) Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial. Rheumatology (Oxford) 44(9):1140–1144
Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Shima C, Bjarnason I, Lofberg R (2003) Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 7(1):48–59
Shimoyama T, Sawada K, Tanaka T, Saito Y, Munakata A, Toyota T, Hiwatshi N, Rasukawa R, Ohara M, Asakura H, Honma T, Kimura K, Koiwai H, Saito Y, Suzuki Y et al (1999) Granulocytapheresis in active ulcerative colitis A multicenter randomized control study. Jpn J Apher 18:117–131
Soerensen H, Schneidewind-Mueller JM, Lange D, Kashiwagi N, Franz M, Yokoyama T, Ramlow W (2006) Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus. Rheumatol Int 26:409–415
Caussin-Schwemling C, Schmitt C, Stoll-Keller F (2001) Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro. J Med Virol 65(1):14–22
Laporte J, Bain C, Maurel P, Inchauspe G, Agut H, Cahour A (2003) Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 101(1):52–57
Castillo I, Rodriguez- Iñigo E, Bartolomé J, de Lucas S, Ortíz-Movilla N, Lòpez-Alcorocho J M, Pardo M, Carreño V (2005) Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 54:682–685
Sawada K, Ohnishi K, Fukunaga K, Kusaka T, Ohdo M, Nagase K, Shimoyama T, Hada T (2003) Granulocyte and monocyte adsorptive apheresis for patients with chronic hepatitis C virus infection: a report on six cases with high plasma viremia. Ther Apher Dial 7(6):547–553
Ueki Y, Yamasaki S, Kanamoto Y, Kawazu T, Yano M, Matsumoto K, Miyake S, Tominaga Y, Iwamoto U, Suemitsu J, Matsuno Y, Sizume Y, Takenaka Y, Eguchi K (2000) Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology (Oxford) 39(2):165–171
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bazzichi, L., Giuliano, T., Rossi, A. et al. Partial remission of refractory RA after adacolumn cytapheresis: a case report. Rheumatol Int 28, 295–297 (2008). https://doi.org/10.1007/s00296-007-0427-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-007-0427-1